These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30014508)

  • 1. Plasma urate and risk of Parkinson's disease: A mendelian randomization study.
    Kobylecki CJ; Nordestgaard BG; Afzal S
    Ann Neurol; 2018 Aug; 84(2):178-190. PubMed ID: 30014508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
    Kia DA; Noyce AJ; White J; Speed D; Nicolas A; ; Burgess S; Lawlor DA; Davey Smith G; Singleton A; Nalls MA; Sofat R; Wood NW
    Ann Neurol; 2018 Aug; 84(2):191-199. PubMed ID: 30014513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Urate, Cancer Incidence, and All-Cause Mortality: A Mendelian Randomization Study.
    Kobylecki CJ; Afzal S; Nordestgaard BG
    Clin Chem; 2017 Jun; 63(6):1151-1160. PubMed ID: 28428355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization of serum urate and parkinson disease progression.
    Simon KC; Eberly S; Gao X; Oakes D; Tanner CM; Shoulson I; Fahn S; Schwarzschild MA; Ascherio A;
    Ann Neurol; 2014 Dec; 76(6):862-8. PubMed ID: 25257975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma urate, lung function and chronic obstructive pulmonary disease: a Mendelian randomisation study in 114 979 individuals from the general population.
    Kobylecki CJ; Vedel-Krogh S; Afzal S; Nielsen SF; Nordestgaard BG
    Thorax; 2018 Aug; 73(8):748-757. PubMed ID: 29187594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically high plasma vitamin C and urate: a Mendelian randomization study in 106 147 individuals from the general population.
    Kobylecki CJ; Afzal S; Nordestgaard BG
    Rheumatology (Oxford); 2018 Oct; 57(10):1769-1776. PubMed ID: 29939348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum urate levels and neurodegenerative outcomes: a prospective cohort study and mendelian randomization analysis of the UK Biobank.
    Zhang T; An Y; Shen Z; Yang H; Jiang J; Chen L; Lu Y; Xia Y
    Alzheimers Res Ther; 2024 May; 16(1):106. PubMed ID: 38730474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.
    McKeigue PM; Campbell H; Wild S; Vitart V; Hayward C; Rudan I; Wright AF; Wilson JF
    Int J Epidemiol; 2010 Jun; 39(3):907-18. PubMed ID: 20348110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher urate in LRRK2 mutation carriers resistant to Parkinson disease.
    Bakshi R; Macklin EA; Logan R; Zorlu MM; Xia N; Crotty GF; Zhang E; Chen X; Ascherio A; Schwarzschild MA
    Ann Neurol; 2019 Apr; 85(4):593-599. PubMed ID: 30761591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants related to urate and risk of Parkinson's disease.
    Hughes KC; Gao X; O'Reilly EJ; Kim IY; Wang M; Weisskopf MG; Schwarzschild MA; Ascherio A
    Parkinsonism Relat Disord; 2018 Aug; 53():4-9. PubMed ID: 29789205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 12. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma urate and risk of Parkinson's disease.
    Weisskopf MG; O'Reilly E; Chen H; Schwarzschild MA; Ascherio A
    Am J Epidemiol; 2007 Sep; 166(5):561-7. PubMed ID: 17584757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression.
    Coneys R; Storm CS; Kia DA; Almramhi M; Wood NW
    Mov Disord; 2021 Sep; 36(9):2182-2187. PubMed ID: 34056740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of plasma urate and risk of Parkinson disease in men and women.
    Gao X; O'Reilly ÉJ; Schwarzschild MA; Ascherio A
    Neurology; 2016 Feb; 86(6):520-6. PubMed ID: 26764029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum urate and the risk of Parkinson's disease: results from a meta-analysis.
    Shen C; Guo Y; Luo W; Lin C; Ding M
    Can J Neurol Sci; 2013 Jan; 40(1):73-9. PubMed ID: 23250131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum urate and lung cancer: a cohort study and Mendelian randomization using UK Biobank.
    Horsfall LJ; Hall IP; Nazareth I
    Respir Res; 2021 Jun; 22(1):179. PubMed ID: 34134711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study.
    Greenberg KI; McAdams-DeMarco MA; Köttgen A; Appel LJ; Coresh J; Grams ME
    Clin J Am Soc Nephrol; 2015 May; 10(5):776-83. PubMed ID: 25717072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
    White J; Sofat R; Hemani G; Shah T; Engmann J; Dale C; Shah S; Kruger FA; Giambartolomei C; Swerdlow DI; Palmer T; McLachlan S; Langenberg C; Zabaneh D; Lovering R; Cavadino A; Jefferis B; Finan C; Wong A; Amuzu A; Ong K; Gaunt TR; Warren H; Davies TL; Drenos F; Cooper J; Ebrahim S; Lawlor DA; Talmud PJ; Humphries SE; Power C; Hypponen E; Richards M; Hardy R; Kuh D; Wareham N; Ben-Shlomo Y; Day IN; Whincup P; Morris R; Strachan MW; Price J; Kumari M; Kivimaki M; Plagnol V; Whittaker JC; ; Smith GD; Dudbridge F; Casas JP; Holmes MV; Hingorani AD;
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):327-36. PubMed ID: 26781229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.